During discussions with the US side, the pharma industry argued that domestic capacity has evolved to serve global demand for affordable medicines rather than any single market, they added.
from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/tV7A3Sb
Home »
IFTTT
,
Information and Updates: ET HealthWorld : ETHealthworld.com
,
Top Health News | Latest Healthcare Sector & Healthcare Industry news
» Healthcare sector contests USTR claim on excess capacity